Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-09-20 | 2024-06 | 0 | N/A | N/A | N/A |
2024-07-01 | 2024-03 | 0 | N/A | N/A | N/A |
2023-02-28 | 2022-12 | -0.19 | N/A | N/A | N/A |
2022-11-08 | 2022-09 | -0.25 | -0.2 | 0.05 | 20.00% |
2022-08-15 | 2022-06 | -0.23 | -0.31 | -0.08 | -34.78% |
2022-05-05 | 2022-03 | 0 | N/A | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2022-11-02 | Cantor Fitzgerald | Upgrade | Overweight | |
2022-03-25 | HC Wainwright & Co. | Upgrade | Buy | |
2021-08-09 | HC Wainwright & Co. | Upgrade | Buy | |
2021-01-21 | Alliance Global Partners | Upgrade | Buy | |
2020-07-31 | HC Wainwright & Co. | Upgrade | Buy | |
2020-05-26 | Dawson James | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2018-09-12 | ABG MANAGEMENT, LTD. | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
2021-03-15 | ASGHAR NAJJAM | Chief Financial Officer | 56.97K | Stock Award(Grant) |
2018-01-23 | ASIA PACIFIC MEDTECH BVI, LTD. | Beneficial Owner of more than 10% of a Class of Security | 8.62M | Sale |
2020-12-15 | FOLLOWWILL DORMAN | Director | 2.13K | Sale |
2021-12-26 | JANDA KIM D | Director | 3.00K | Sale |
2022-12-20 | JI HENRY H | Chief Executive Officer | 0.00 | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2022-12-30 | State Street Corporation | 50.64M | 15.56M | 10.73% |
2022-12-30 | Blackrock Inc. | 39.42M | 12.11M | 8.35% |
2022-12-30 | Vanguard Group, Inc. (The) | 29.54M | 9.08M | 6.26% |
2022-12-30 | Geode Capital Management, LLC | 8.91M | 2.74M | 1.89% |
2022-12-30 | B. Riley Financial, Inc. | 5.22M | 1.60M | 1.11% |
2022-12-30 | B. Riley Securities, Inc. | 5.22M | 1.60M | 1.11% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2022-12-30 | SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 40.89M | 12.56M | 8.66% |
2022-09-29 | Vanguard Total Stock Market Index Fund | 12.84M | 3.95M | 2.72% |
2022-12-30 | iShares Russell 2000 ETF | 10.36M | 3.18M | 2.20% |
2022-09-29 | Vanguard Extended Market Index Fund | 5.51M | 1.69M | 1.17% |
2022-12-30 | Direxion Shares ETF Tr-Direxion Daily S&P Biotech Bull 3x Sh | 4.27M | 1.31M | 0.91% |
2022-12-30 | iShares Russell 2000 Value ETF | 4.11M | 1.26M | 0.87% |
Split | Date |
---|---|
0.04 : 1 | 2013-08-01 |
0.1 : 1 | 2008-10-07 |
-
This thing will retest $4 before it "rockets" again... $SRNE
-
All this is fucking trap! Stock going down... we definitely will get rid of it . Then boob news pops up. Again fucked up.
-
$SRNE Sold my 800 shares for a small loss, too much money to be made else where.
-
Just bought 5,000 shares @ $5... too much upside potential $$$ for little risk at this value... $SRNE
-
$SRNE Call every lawyer chasing Sorrento and tell them how you feel! Keep them busy so our boy Henry Ji can stay busy in the lab.
-
$SRNE LMAO these bears are soo full of shit, it’s hilarious. Stop working so hard lol we believe you ji “isn’t a doctor”, “they have no money”, “lawsuits incoming” lol we get it. No one gives a shit, in Henry we trust bitch! COVID-SHIELD!
-
First stock ever shorted and in the money GraceyTrain- well done man, for now, and ty for updates every 20mins. I’m still spending your cash from the last spike a few weeks back remember that, or is that past your entry.. our secret let’s do the hard math is 180% better than 50%?
-
Here comes the next wave.
-
STI-6129
-
Awesome news just released FDA approval for IND application.
-
$SRNE will be above $8 by Friday
-
Brokerage Dawson James and HC Wainwright both rate this stock as a buy with a target price of $24.00 per share.
-
Brokerage Dawson James and HC Wainwright both rate this stock as a buy with a target price of $24.00 per share price.
-
Brokerage Dawson James and HC Wainwright both rate this stock as a buy with a target price of $24.00 per share price.
-
Buy Buy Buy, this is a great price, you won’t regret it $SRNE
-
@Godfather is full of shit. Hope you covered your loss you misleading piece of shit $SRNE in Henry we trust, not your photo shopped posts
-
$SRNE Sorrento on go with study of antibody-drug conjugate amyloidosis https://seekingalpha.com/news/3577506-sorrento-on-go-study-of-antibody-drug-conjugate-amyloidosis
-
East or west @SRNE IS THE Best.
-
$SRNE Lol these bears posting nonsense trying to scare you out of your money. There’s nothing to be scared about investors! All the facts are there and this baby is going to keep rising!
-
-
Sorrento Resources to Sell Three Newfoundland Properties to Gold Hunter
newsfilecorp.com • -
Scilex: Sorrento's Better Half, Or Its Entangled, Erratic Mover?
seekingalpha.com • -
The $75 Million Reason Sorrento (SRNE) Stock Is Moving Today
investorplace.com • -
Penny Stocks To Buy? 7 To Watch Now After Big News
pennystocks.com • -
How to Stay Disciplined When Investing in Penny Stocks
pennystocks.com • -
Best Penny Stocks To Buy Now? 4 With Big News In February
pennystocks.com • -
How to Know When to Sell Penny Stocks
pennystocks.com •